STAGE IV LUNG CANCER AJCC V8

This study tested whether adding an immunotherapy drug (bintrafusp alfa) to standard chemotherapy (docetaxel) helps people with advanced non-small cell lung cancer whose disease got worse after prior treatment. Only 10 people enrolled before the study was stopped early. The goal …

This early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combination was safe and could s…

This study tested a combination of two immunotherapy drugs (BMS-986218 and nivolumab) plus precise radiation for people with advanced solid tumors that had spread. The goal was to see if this approach could help control the cancer and check for side effects. Only 13 people took p…

This early-phase trial tested a combination of two immunotherapy drugs (atezolizumab and varlilumab) plus radiation in 16 people with advanced non-small cell lung cancer that had stopped responding to prior treatment. The main goal was to check safety and side effects. The study …

This study tested several targeted drugs (ALK inhibitors) and chemotherapy in people with a specific type of advanced lung cancer called ALK-positive non-squamous non-small cell lung cancer. The goal was to see which treatment worked best based on the patient's tumor markers. Onl…

This study tested two drugs, bintrafusp alfa and pimasertib, in people whose cancer had spread to the brain. The goal was to find the best dose and see if the combination could slow or stop tumor growth. The trial was stopped early after enrolling only 8 participants, so no clear…

This study tested a mobile app that helps people with brain metastases from breast or lung cancer follow a time-restricted eating plan (eating only during certain hours). The goal was to see if this approach could reduce memory and thinking problems after stereotactic radiosurger…